| The potential role of miRNAs in the pathogenesis of cardiovascular diseases–a focus on signaling pathways interplay EG Khidr, AI Abulsoud, AA Doghish, HA El-Mahdy, A Ismail, MS Elballal, ... Pathology-Research and Practice 248, 154624, 2023 | 41 | 2023 |
| miRNAs as potential game-changers in retinoblastoma: Future clinical and medicinal uses AS Doghish, HAM Moustafa, MS Elballal, OM Sarhan, SF Darwish, ... Pathology-Research and Practice 247, 154537, 2023 | 40 | 2023 |
| miRNAs orchestration of gallbladder cancer–particular emphasis on diagnosis, progression and drug resistance RK Shahin, MA Elkady, AI Abulsoud, NM Abdelmaksoud, SSA Mageed, ... Pathology-Research and Practice 248, 154684, 2023 | 38 | 2023 |
| Androgen receptor blockade by flutamide down-regulates renal fibrosis, inflammation, and apoptosis pathways in male rats S Allam, EGE Elsakka, A Ismail, AS Doghish, AM Yehia, MA Elkady, ... Life Sciences 323, 121697, 2023 | 38 | 2023 |
| Canagliflozin-loaded chitosan-hyaluronic acid microspheres modulate AMPK/NF-κB/NLRP3 axis: A new paradigm in the rectal therapy of ulcerative colitis M Nasr, S Cavalu, S Saber, ME Youssef, AM Abdelhamid, HI Elagamy, ... Biomedicine & Pharmacotherapy 153, 113409, 2022 | 36 | 2022 |
| Decoding the role of miRNAs in multiple myeloma pathogenesis: a focus on signaling pathways AM Yehia, EGE Elsakka, AI Abulsoud, NM Abdelmaksoud, A Elshafei, ... Pathology-Research and Practice 248, 154715, 2023 | 34 | 2023 |
| miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma MA Elkady, AM Yehia, EGE Elsakka, AI Abulsoud, NM Abdelmaksoud, ... Pathology-Research and Practice 248, 154704, 2023 | 34 | 2023 |
| Ambroxol, a mucolytic agent, boosts HO‐1, suppresses NF‐κB, and decreases the susceptibility of the inflamed rat colon to apoptosis: a new treatment option for treating … S Cavalu, H Sharaf, S Saber, ME Youssef, AM Abdelhamid, AAE Mourad, ... The FASEB Journal 36 (9), e22496, 2022 | 34 | 2022 |
| miRNAs orchestration of cardiovascular diseases–particular emphasis on diagnosis, and progression EGE Elsakka, AI Abulsoud, HA El-Mahdy, A Ismail, MS Elballal, ... Pathology-Research and Practice 248, 154613, 2023 | 30 | 2023 |
| Alvespimycin exhibits potential anti-TGF-β signaling in the setting of a proteasome activator in rats with bleomycin-induced pulmonary fibrosis: a promising novel approach OA Mohammed, MA Abdel-Reheim, LA Saleh, MMS Alamri, J Alfaifi, ... Pharmaceuticals 16 (8), 1123, 2023 | 29 | 2023 |
| Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer’s disease NM Abdelmaksoud, AAM Sallam, AI Abulsoud, WA El-Dakroury, ... Pathology-Research and Practice 253, 155007, 2024 | 27 | 2024 |
| Melodic maestros: unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of malignant pleural mesothelioma MA Abd-Elmawla, SSA Mageed, TM Al-Noshokaty, MS Elballal, ... Pathology-Research and Practice 250, 154817, 2023 | 27 | 2023 |
| Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: Novel insights on autophagy, apoptosis, and pyroptosis R Abdelhady, S Saber, M Ahmed Abdel-Reheim, M Mohammad S. Alamri, ... Frontiers in Pharmacology 14, 1239025, 2023 | 24 | 2023 |
| Carbocisteine as a modulator of Nrf2/HO-1 and NFκB interplay in rats: new inspiration for the revival of an old drug for treating ulcerative colitis AM Abdelhamid, ME Youssef, S Cavalu, G Mostafa-Hedeab, A Youssef, ... Frontiers in pharmacology 13, 887233, 2022 | 24 | 2022 |
| miRNAs driving diagnosis, prognosis and progression in Merkel cell carcinoma TM Al-Noshokaty, MS Elballal, GK Helal, AI Abulsoud, SS Elshaer, ... Pathology-Research and Practice 249, 154763, 2023 | 23 | 2023 |
| Medical students' perception and academic performance after team-based and seminar-based learning in human anatomy AM Aboregela, HMA Sonpol, AS Metwally, AM El-Ashkar, AA Hashish, ... Journal of Taibah University Medical Sciences 18 (1), 65-73, 2023 | 23 | 2023 |
| Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling S Saber, EE Abd El-Fattah, AM Abdelhamid, AAE Mourad, ... Biomedicine & Pharmacotherapy 158, 114196, 2023 | 23 | 2023 |
| Rumex vesicarius L. boosts the effectiveness of sorafenib in triple-negative breast cancer by downregulating BCl2, mTOR, and JNK, and upregulating p21 expression A Ghanem, MA Ali, MA Elkady, SSA Mageed, MA El Hassab, ... Pathology-Research and Practice 250, 154807, 2023 | 21 | 2023 |
| The interplay between toxoplasmosis and host miRNAs: Mechanisms and consequences AS Doghish, MA Ali, MA Elrebehy, HH Mohamed, R Mansour, A Ghanem, ... Pathology-Research and Practice 250, 154790, 2023 | 19 | 2023 |
| Ganetespib (STA-9090) augments sorafenib efficacy via necroptosis induction in hepatocellular carcinoma: Implications from preclinical data for a novel therapeutic approach S Saber, AM Hasan, OA Mohammed, LA Saleh, AA Hashish, MMS Alamri, ... Biomedicine & Pharmacotherapy 164, 114918, 2023 | 18 | 2023 |
Ahmed Soliman DoghishBadr University in CairoE-mail megerősítve itt: azhar.edu.eg